Key Highlights
- EFA had net Assets of $76.13 billion as of 23 October 2026, and the fund's expense ratio is 0.32%.
- The fund holds 656 securities and tracks the MSCI EAFE Index (Net).
- The most recent distribution was $1.636388 per share, paid on 18 June 2026.
The iShares MSCI EAFE ETF (NYSEARCA:EFA) is a developed-market Equity fund covering Europe, Australasia and the Far East. On 23 October 2026 the fund had a NAV of $102.58 and a closing price of $102.63, and net assets stood at $76.13 billion. The NAV moved by -$0.51 (-0.49%) on the day.
The fund seeks to track an index of large- and mid-cap developed market equities outside the U.S. and Canada, for international diversification. It is listed on NYSE Arca, has traded since 14 August 2001 and pays distributions semi-annual. This article sets out its structure, portfolio, costs and risk characteristics.
Fund Snapshot
iShares MSCI EAFE ETF reported a NAV of $102.58 and a closing price of $102.63 on 23 October 2026, a premium of 0.05%. There were 742,200,000 shares outstanding, and the 30-day median bid/ask spread was 0.01%. Daily Volume was 9,997,878 shares, compared with a 30-day average of 15,281,059. The non-fair-value NAV was $102.73.
Index and Objective
The fund tracks the MSCI EAFE Index (Net) and is passively managed against it. Its stated aim is to track an index of large- and mid-cap developed market equities outside the U.S. and Canada, for international diversification. The portfolio held 656 securities as of 23 October 2026. The fund may use exchange-traded Index Futures to offset cash and receivables while tracking its benchmark.
Top Holdings
The ten largest positions in the portfolio were ASML Holding (2.88%), Roche (1.56%), Shell (1.47%), HSBC Holdings (1.46%), Novartis (1.34%), Nestlé (1.23%), AstraZeneca (1.22%), SAP (1.15%), Mitsubishi UFJ Financial Group (1.06%), Siemens (0.98%). Together they represent 14.35% of the fund.
International Developed Markets
EFA covers large- and mid-cap companies in developed markets outside the United States and Canada. Its top holdings are European and Japanese names such as ASML, Roche, Shell, HSBC and Novartis, and the fund pays distributions twice a year, in June and December. The fund notes that its total return may appear to diverge from its benchmark because of systematic Fair Value pricing.
Costs and Distributions
The total expense ratio stated in the prospectus is 0.32%. The fund's most recent distribution had a record and ex-date of 15 June 2026, was payable on 18 June 2026 and totalled $1.636388 per share, all from income. The prior distribution was $1.727900 per share, with a date of 16 December 2025.
Valuation and Risk Characteristics
As of 23 October 2026 the fund's portfolio had a P/E ratio of 18.86 and a P/B ratio of 2.34. As of 30 September 2026 its equity Beta was 0.64 and its three-year Standard Deviation 12.37%. These figures describe the portfolio's valuation and sensitivity to market movements and are not forecasts. The fund notes that international investing involves risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial Volatility from adverse political, economic or other developments.
Morningstar Ratings
Morningstar gave the fund an overall rating of 3 stars, rated against 640 Foreign Large Blend funds as of 30 September 2026, and a Silver Medalist Rating effective 5 October 2026.
Closing Overview
iShares MSCI EAFE ETF (EFA) reported 656 holdings, $76.13 billion in net assets and a 0.32% expense ratio as of 23 October 2026.



_11_12_2026_12_34_58_437217.jpg)

_11_12_2026_12_35_07_953080.jpg)
Please wait processing your request...